JP2025513745A5 - - Google Patents
Info
- Publication number
- JP2025513745A5 JP2025513745A5 JP2024557632A JP2024557632A JP2025513745A5 JP 2025513745 A5 JP2025513745 A5 JP 2025513745A5 JP 2024557632 A JP2024557632 A JP 2024557632A JP 2024557632 A JP2024557632 A JP 2024557632A JP 2025513745 A5 JP2025513745 A5 JP 2025513745A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2022/083269 | 2022-03-28 | ||
| CN2022083269 | 2022-03-28 | ||
| PCT/CN2023/084213 WO2023185778A1 (en) | 2022-03-28 | 2023-03-28 | Novel anti-fgfr2 antibodies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025513745A JP2025513745A (ja) | 2025-04-30 |
| JPWO2023185778A5 JPWO2023185778A5 (https=) | 2026-04-08 |
| JP2025513745A5 true JP2025513745A5 (https=) | 2026-04-08 |
Family
ID=88199423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024557632A Pending JP2025513745A (ja) | 2022-03-28 | 2023-03-28 | 新規抗ｆｇｆｒ２抗体 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4499701A4 (https=) |
| JP (1) | JP2025513745A (https=) |
| KR (1) | KR20250042203A (https=) |
| CN (1) | CN119110806A (https=) |
| AU (1) | AU2023243773A1 (https=) |
| CA (1) | CA3246949A1 (https=) |
| IL (1) | IL315970A (https=) |
| MX (1) | MX2024011805A (https=) |
| WO (1) | WO2023185778A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202600596A (zh) * | 2024-03-04 | 2026-01-01 | 大陸商杭州中美華東製藥有限公司 | 抗ＦＧＦＲ２ｂ抗體、其抗體藥物偶聯物及其用途 |
| CN118772279B (zh) * | 2024-06-28 | 2025-03-25 | 北京普利米特生物科技有限公司 | 抗FGFR2b抗体或其抗原结合片段及其用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014089193A1 (en) * | 2012-12-04 | 2014-06-12 | Aveo Pharmaceuticals, Inc. | Anti-fgfr2 antibodies |
| PH12021552742A1 (en) * | 2013-08-01 | 2022-05-23 | Five Prime Therapeutics Inc | Afucosylated anti-fgfr2iiib antibodies |
| KR20220019839A (ko) * | 2013-10-08 | 2022-02-17 | 다이이찌 산쿄 가부시키가이샤 | 항 fgfr2 항체와 타제의 조합 |
| EP3287522A4 (en) * | 2015-04-20 | 2019-03-27 | Daiichi Sankyo Company, Limited | DETECTION OF FGFR2 |
| US20220010020A1 (en) * | 2018-10-05 | 2022-01-13 | Five Prime Therapeutics, Inc. | Anti-FGFR2 Antibody Formulations |
| CA3160810A1 (en) * | 2019-12-24 | 2021-07-01 | Dizal (Jiangsu) Pharmaceutical Co., Ltd. | Novel anti-fgfr2b antibodies |
| MX2022007961A (es) * | 2019-12-24 | 2022-07-12 | Dizal Jiangsu Pharmaceutical Co Ltd | Nuevos anticuerpos anti-fgfr2b. |
| US20230052256A1 (en) * | 2019-12-24 | 2023-02-16 | Dizal (Jiangsu) Pharmaceutical Co., Ltd. | Novel anti-fgfr2b antibodies |
-
2023
- 2023-03-28 AU AU2023243773A patent/AU2023243773A1/en active Pending
- 2023-03-28 CN CN202380031311.1A patent/CN119110806A/zh active Pending
- 2023-03-28 JP JP2024557632A patent/JP2025513745A/ja active Pending
- 2023-03-28 CA CA3246949A patent/CA3246949A1/en active Pending
- 2023-03-28 WO PCT/CN2023/084213 patent/WO2023185778A1/en not_active Ceased
- 2023-03-28 EP EP23778143.0A patent/EP4499701A4/en active Pending
- 2023-03-28 IL IL315970A patent/IL315970A/en unknown
- 2023-03-28 KR KR1020247035207A patent/KR20250042203A/ko active Pending
-
2024
- 2024-09-25 MX MX2024011805A patent/MX2024011805A/es unknown